Abiopharma

🔍 Lilly III John Osborne (Executive)

Company: Figma, Inc. (FIG)

Report Date: 2026-08-28

Detailed Transactions and Holdings:

• Acquired 330,306 shares of Class A Common Stock (Direct)
  Date: 2026-08-28 | Code: J | equity_swap_involved: 0 | shares_owned_after: 799,396.00 | transaction_form_type: 5 | Footnotes: F1, F2
• Acquired 5,460 shares of Class A Common Stock (Direct)
  Date: 2026-08-28 | Code: J | equity_swap_involved: 0 | shares_owned_after: 24,700.00 | transaction_form_type: 5 | Footnotes: F3

Footnotes:

• F1: Represents shares of Class A Common Stock received pursuant to pro rata distributions by Greylock XIV Limited Partnership and Greylock XIV-A Limited Partnership to their respective partners. The distributions were made in accordance with the exemption afforded by Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
• F2: These shares are held of record by a revocable living trust of which the Reporting Person is a trustee.
• F3: Represents shares of Class A Common Stock received pursuant to a pro rata distribution by Greylock XIV Principals to its partners. The distribution was made in accordance with the exemption afforded by Rule 16a-9 of the Securities Exchange Act of 1934, as amended.